Brief: Xbiotech Says First Audit In New Manufacturing Facility Shows Compliance With Gmp Guidelines
03/12/2018 13:49
Dec 3 (Reuters) - XBiotech Inc XBIT.O :
* XBIOTECH ANNOUNCES SUCCESSFUL COMPLETION OF GMP AUDIT
* XBIOTECH INC - RECENTLY RETIRED ITS OLD OPERATIONS, WHICH
INCLUDED A GMP MANUFACTURING FACILITY
* XBIOTECH INC - FIRST AUDIT IN COMPANY'S NEW MANUFACTURING
FACILITY SHOWS COMPLIANCE WITH GMP GUIDELINES
* XBIOTECH INC - AUDIT WAS CONDUCTED IN CONNECTION WITH
XBIOTECH'S
DISTRIBUTION IN EUROPE OF ITS US-MANUFACTURED BIOLOGICAL DRUG
PRODUCT
Source text for Eikon: ID:nGNERZlCY
Further company coverage: XBIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke